Research

rs353478 — UIMC1 UIMC1 DNA Damage Response Variant

An intronic variant in UIMC1 (RAP80), the core ubiquitin-binding subunit of the BRCA1-A complex that recruits BRCA1 to DNA double-strand breaks; the T allele is associated with earlier age at natural menopause, implicating reduced DNA repair fidelity in accelerated ovarian ageing

Strong Risk Factor Share

Details

Gene
UIMC1
Chromosome
5
Risk allele
T
Clinical
Risk Factor
Evidence
Strong

Population Frequency

CC
33%
CT
49%
TT
18%

See your personal result for UIMC1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

UIMC1/RAP80 — The Ubiquitin Reader That Guards the Ovarian Clock

Every time a cell divides, its DNA faces the risk of double-strand breaks — the most dangerous class of DNA damage, capable of triggering chromosomal rearrangement or cell death if left unrepaired. The primordial follicle pool that determines a woman's reproductive lifespan is exquisitely sensitive to this damage: follicle cells that cannot repair DNA accurately are eliminated by apoptosis, gradually depleting the reserve that supports fertility and hormonal function. UIMC111 UIMC1
also known as RAP80 — Receptor-Associated Protein 80; encodes the ubiquitin-binding scaffold subunit of the BRCA1-A deubiquitin complex at DNA damage sites
sits at the centre of this repair machinery. The rs353478 variant in an intron of UIMC1 emerged from the largest-ever GWAS of age at natural menopause as one of the strongest signals in the study — implicating this DNA repair checkpoint in the pace of ovarian ageing.

The Mechanism

When a double-strand break occurs, the histone E3 ligase RNF8 attaches [Lys63-linked ubiquitin chains | K63-linked polyubiquitin; a non-degradative ubiquitin signal that serves as a molecular scaffold for recruiting repair factors, as opposed to K48-linked chains which tag proteins for proteasomal degradation] to histones H2A and H2AX in the chromatin surrounding the break. RAP80 (UIMC1) contains tandem ubiquitin-interacting motifs (UIMs) that bind these K63-linked chains with high specificity, anchoring the entire BRCA1-A complex — BRCA1, BARD1, Abraxas, BRCC36, and KIAA0157 — directly to the damage site.

Recent work has revealed that RAP80 does not simply act as a passive scaffold. Qin et al. 202322 Qin et al. 2023
RAP80 phase separation at DNA double-strand break promotes BRCA1 recruitment. Nucleic Acids Research, 51:10487–10503
showed that RAP80's intrinsically disordered N-terminal region drives liquid-liquid phase separation at break sites, forming dynamic condensates that concentrate BRCA1 and enhance repair efficiency. Disrupting this condensation — by mutating the IDR or blocking ubiquitin binding — significantly impaired homologous recombination and increased radiation sensitivity. Separately, Tang et al. 202433 Tang et al. 2024
DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair. PNAS, 121:e2401785121
demonstrated that the methyltransferase DOT1L must first methylate specific RAP80 lysine residues before RAP80 can engage ubiquitinated H2A — adding a post-translational regulatory layer to BRCA1-A complex assembly.

Although rs353478 is intronic and does not alter the RAP80 protein sequence, intronic variants can modulate splicing efficiency, transcript abundance, and isoform ratios. The T allele at this position tags a haplotype within UIMC1 that appears, across many thousands of women, to be associated with a modestly reduced capacity to maintain ovarian follicle DNA integrity — accelerating the pace at which the primordial follicle pool is depleted.

The Evidence

The definitive evidence comes from Ruth et al. 202144 Ruth et al. 2021
Genetic insights into biological mechanisms governing human ovarian ageing. Nature 596:393–397
, a GWAS of 201,323 women across 35 studies. The rs353478-C allele was associated with later age at natural menopause at beta = +0.298 years per allele (p = 3 × 10⁻²⁶⁸), placing the UIMC1 locus among the top three effect sizes in the entire study. The authors systematically enriched for DNA damage response genes among the top menopause loci, confirming that RAP80/BRCA1-A pathway integrity is a genuine determinant of the rate of ovarian ageing — not a GWAS artifact.

The UIMC1/5q35.2 locus was first detected in an earlier, smaller GWAS by He et al. 200955 He et al. 2009
Nature Genetics 41:646–650
in 17,438 women, reaching genome-wide significance alongside three other loci (MCM8, BRSK1, SYCP2L), all of which are now understood to participate in meiotic DNA repair or chromosome segregation fidelity. The biological coherence of this cluster — ovarian ageing GWAS hits enriched in DNA repair genes — provided the mechanistic logic that the 2021 mega-analysis confirmed at scale.

Practical Implications

For TT homozygotes, the T allele reduces each copy's contribution to ovarian reserve maintenance, on average compressing the reproductive window by approximately 0.6 years (two alleles × 0.298 years) relative to CC homozygotes. At the population level this is statistically clear; for individuals it means a slight shift in the probability distribution of menopausal timing, not a fixed outcome. The effect is meaningful when combined with other ovarian reserve markers and life circumstances.

The practical implications center on fertility timing awareness, ovarian reserve monitoring, and nutritional support for DNA repair pathways. Folate, vitamin B12, and zinc are cofactors in DNA synthesis and repair; ensuring adequate status of these micronutrients supports the cellular machinery that UIMC1 participates in. These supplements do not reverse the genetic variant's effect, but they remove avoidable nutritional bottlenecks from the same repair pathways.

Interactions

rs16991615 (MCM8): The MCM8 minichromosome maintenance helicase is required for meiotic DNA repair in oocytes. MCM8 rs16991615 is one of the most replicated ANM GWAS loci and, like rs353478, acts through DNA repair pathway integrity. Women carrying risk alleles at both UIMC1 and MCM8 may experience compounded effects on ovarian reserve depletion rate, as the two genes operate at adjacent steps in the homologous recombination pathway — BRCA1-A recruitment (UIMC1) and helicase-mediated strand unwinding for repair synthesis (MCM8).

rs2303369 (BRSK1): The brain-specific serine/threonine kinase BRSK1 regulates the DNA damage checkpoint in meiotic cells. The BRSK1 locus at 19q13.42 was identified alongside UIMC1 in the He et al. 2009 GWAS and confirmed in Ruth 2021. A compound action for women carrying risk alleles at both UIMC1 and BRSK1 would centre on earlier ovarian reserve assessment and intensified DNA repair nutrient support, as both variants converge on the fidelity of meiotic double-strand break resolution. Evidence for the combined effect is indirect (co-identification in GWAS enrichment analyses rather than formal interaction testing); a supervisor compound action at moderate evidence level would be appropriate.

Nutrient Interactions

folate increased_need
vitamin B12 increased_need
zinc increased_need

Genotype Interpretations

What each possible genotype means for this variant:

CC “Protective Genotype” Beneficial

Two copies of the ovarian-reserve-protective allele — optimal DNA repair signalling at this locus

You carry two C alleles at rs353478 in UIMC1 (RAP80), the allele associated with later age at natural menopause in the largest-ever ovarian ageing GWAS (Ruth et al. 2021, 201,323 women). Each C allele contributes approximately 0.298 years of additional ovarian longevity; CC homozygotes sit at the beneficial end of the distribution at this locus. Approximately 33% of people share this genotype globally; in Europeans the frequency is approximately 25%.

This does not guarantee late menopause — many other genetic loci and environmental factors shape the reproductive timeline — but at this particular checkpoint in the BRCA1-A DNA repair pathway, your variant configuration is favourable.

CT “Intermediate Reserve” Intermediate Caution

One copy of the protective allele and one risk allele — modestly reduced ovarian DNA repair signalling

At a mechanistic level, UIMC1/RAP80 is the ubiquitin-binding scaffold that anchors the BRCA1-A complex to K63-linked ubiquitin chains deposited at double-strand breaks. A subtle reduction in RAP80 availability or efficiency — even without a coding change — could increase the rate at which follicle cells accumulate unresolved DNA damage and undergo apoptosis, accelerating the depletion of the primordial follicle pool.

For most CT carriers, the effect will not be perceptible in clinical ovarian reserve tests unless combined with other contributory factors (other ANM-risk alleles, suboptimal folate/zinc status, chemotherapy exposure, or reproductive history). Awareness of the genotype supports proactive rather than reactive management of fertility timing.

TT “Reduced Reserve Signalling” High Risk Warning

Two copies of the ovarian-reserve-risk allele — attenuated UIMC1 DNA repair signalling at this locus

The RAP80 protein operates at a critical juncture in the DNA damage response: it reads Lys63-linked ubiquitin chains deposited by RNF8 at double-strand breaks, forming liquid-liquid phase-separation condensates that concentrate the BRCA1-A complex (BRCA1, BARD1, Abraxas, BRCC36, KIAA0157) at the break site. Disrupting this assembly — experimentally or through reduced RAP80 availability — impairs homologous recombination, the high-fidelity repair pathway used preferentially in meiotic and early follicular cells.

The UIMC1 locus is part of a broader biological theme confirmed in the Ruth 2021 mega-GWAS: among the top ~300 ANM loci, DNA damage response genes were dramatically over-represented. Fellow loci MCM8 (meiotic helicase) and BRSK1 (meiotic checkpoint kinase) were identified in the same 2009 founding GWAS alongside UIMC1 at 5q35.2. The convergence of multiple independent genetic signals on the same pathway provides strong mechanistic plausibility.

For TT homozygotes, the effect of this variant is the same biological direction as, but independent of, chemotherapy-induced ovarian damage — the Homer et al. 2017 study confirmed that chemotherapy oophoropathy has distinct biology. This means the genotype's impact is most relevant to natural fertility trajectory, not to predicting chemotherapy response.

Prioritise early ovarian reserve testing, timely fertility planning, and nutritional optimisation of DNA repair cofactors. If AMH is already borderline low, seek reproductive specialist input promptly — ovarian reserve does not recover with time.